Article Text

other Versions

PDF
Targeting hypoxia in inflammatory bowel disease
  1. Sean P Colgan
  1. Department of Medicine and the Mucosal Inflammation Program, University of Colorado School of Medicine, Aurora, CO, USA
  1. Correspondence to Sean P Colgan, University of Colorado School of Medicine, 12700 E, 19th Ave, MS B-146, Aurora, CO 80045, USA; sean.colgan{at}ucdenver.edu

Abstract

In this review, I summarize some of the recent insight into pharmacological targeting of hypoxia in disease models. Studies from cultured cell systems, animal models, and translation to human patients have revealed that posttranslational modifications of individual proteins within NF-κB and hypoxia-inducible factor pathways serve as ideal targets for analysis in disease models. Studies defining differences and similarities between these responses have taught us a number of important lessons about the complexity of the inflammatory response. A clearer definition of these pathways has provided new insight into disease pathogenesis and, importantly, the potential for new therapeutic targets.

  • inflammation
  • hypoxia
  • mucosa
  • epithelia
  • transcription
  • translation

Statistics from Altmetric.com

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.